• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HOLOGIC INC. CYTOLYT SOLUTION; PRESERVATIVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HOLOGIC INC. CYTOLYT SOLUTION; PRESERVATIVE Back to Search Results
Device Problem Use of Device Problem (1670)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 08/01/2013
Event Type  Injury  
Event Description
A customer in (b)(6) reported a (b)(6) pt (male) swallowed cytolyt solution while at the hosp (b)(6).When the accident happened, the pt was transferred ot the antivenin unit directed by the (b)(6).The pt was monitored and treated by (b)(6) from the (b)(6) of the hosp.Once they received the exact composition of the cytolyt and by comparing the reported % of methanol with the toxicological date, the antivenin unit closed the incident and discharged the pt from the unit.(b)(6) (eu): per the content of the current revision of the (b)(6) guidelines on a medical device vigilance system, this won't be classified as a reportable event.The rationale is as follows: there is no report of vial or cap mfg issues.Our labelling is in line with the current eu guidelines and we list appropriate warnings in our ifu regarding use of the product.This appears to be a case of clinical negligence and the onus is on the user to report via their clinical governance procedures.This would be regarded as a case of abnormal use of the product.The current (b)(6) guidelines also state: 5.1.5.3 consideration for handling abnormal use abnormal use needs not be reported by the mfr to the national competent authority under the reporting procedures.Abnormal use should be handled by the health care facility and appropriate regulatory authorities under specific appropriate schemes not covered by this document.If mfrs become aware of instances of abnormal use, they may bring this to the attention of other appropriate organizations and healthcare facility personnel.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CYTOLYT SOLUTION
Type of Device
PRESERVATIVE
Manufacturer (Section D)
HOLOGIC INC.
250 campus drive
marlborough MA 01752
Manufacturer Contact
eva maxwell
2 navigator rd
londonderry, NH 03053
5082638922
MDR Report Key4101636
MDR Text Key4702573
Report Number1222780-2014-00144
Device Sequence Number1
Product Code IFB
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Unknown
Reporter Occupation Other
Type of Report Initial
Report Date 08/12/2014
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Other
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/12/2014
Initial Date FDA Received08/27/2014
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
Patient Age88 YR
-
-